Microbiome related immunotherapies
AssigneeFinch Therapeutics Holdings LLC
InventorsJoseph LOBACKI, Ulrich THIENEL, Zain KASSAM, Marina SANTIAGO
Life of this patent
Estimating the term…
Abstract
The present invention generally relates to therapeutic compositions and methods for treating cancer patients. The compositions and methods can increase efficacy of an anti-cancer therapy, or treat, prevent, or inhibit an oncology-treatment induced condition (OTIC) induced by an anti-cancer therapy. The therapeutic compositions comprise microbial compositions and, optionally, an anti-cancer therapeutic agent. The methods comprise administering a therapeutic composition comprising a microbial composition and administering an anti-cancer therapy.
Claims21
-143. (canceled)
A method of treating melanoma in a subject in need thereof, the method comprising administering to the subject an immunotherapy and a microbial composition comprising a community of fecal bacteria derived from a stool of a healthy human donor.
A method of treating melanoma in a subject in need thereof, the method comprising administering to the subject a checkpoint inhibitor and a mixture of fecal bacteria extracted from a stool of a healthy human donor.
Dependencies are inferred from the claim text.